Evidence map›Paper›PMID 40075511›Full record

ArticleInternational journal of retina and vitreous2025

Correction: Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort's analysis.

Mansour Bahardoust, Yadollah Mehrabi, Farzad Hadaegh, Davood Khalili, Ali Delpisheh

Abstract readPublished Erratum
In one paragraph

Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mansour BahardoustDepartment of Epidemiology, School of Public Health & Safety, Shahid Beheshti University of Medical Sciences, Velenjak, 7th Floor, Bldg No.2 SBUMS, Arabi Ave, Tehran, Tehran Province, Iran.
Yadollah MehrabiDepartment of Epidemiology, School of Public Health & Safety, Shahid Beheshti University of Medical Sciences, Velenjak, 7th Floor, Bldg No.2 SBUMS, Arabi Ave, Tehran, Tehran Province, Iran.
Farzad HadaeghPrevention of Metabolic Disorders Research Center, Division of Biostatistics and Epidemiology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Velenjak, Yaman St, Aarabi St, No.24, Tehran, Iran.
Davood KhaliliPrevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. dkhalili@endocrine.ac.ir.
Ali DelpishehDepartment of Epidemiology, School of Public Health & Safety, Shahid Beheshti University of Medical Sciences, Velenjak, 7th Floor, Bldg No.2 SBUMS, Arabi Ave, Tehran, Tehran Province, Iran. alidelpisheh@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40075511
PMCPMC11905429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.